Medical Condition News

RSS

Talk therapy improves PTSD, says Walter Reed National Military Medical Center chief

Cmdr. Russell B. Carr, M.D., acting chief of the psychiatry department at Walter Reed National Military Medical Center, stated that almost everyone seen at Walter Reed and in clinics throughout the Department of Defense is suicidal. He also estimates that the best PTSD treatments in use today do not work for 30 to 40 percent of patients.

25 Apr 2013

Thought Leaders Consortium discusses new vision for medicine in healthcare

Defining a new vision for medicine was the mission of the consortium of global leaders in healthcare who gathered in Seattle, Wash., April 12 - 14 for the first "Thought Leaders Consortium" hosted by the Personalized Lifestyle Medicine Institute.

25 Apr 2013

Perosphere, Daiichi Sankyo sign clinical trial agreement

Perosphere Inc. and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that they have entered into a clinical trial agreement under which Daiichi Sankyo will support and co-sponsor a phase 1 clinical study testing the safety, tolerability and effectiveness of PER977 to reverse the anticoagulant activity of edoxaban, Daiichi Sankyo's investigational oral, once-daily, direct factor Xa-inhibitor.

25 Apr 2013

Omeros presents clinical data of OMS302 on reducing pupil constriction during ILR at ASCRS meeting

Omeros Corporation today reported analyses of Phase 2 and Phase 3 clinical data showing the favorable impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement.

25 Apr 2013

Personalized knee replacement: an interview with Dr Martin, Preferred Orthopedics of the Palm Beaches

Knee replacement surgery has traditionally been performed using off-the-shelf implants because of the limitations of technology. As with most industries, evolution does occur.

25 Apr 2013

Study: Melatonin delays symptom onset, reduces mortality in mouse model of ALS

Melatonin injections delayed symptom onset and reduced mortality in a mouse model of the neurodegenerative condition amyotrophic lateral sclerosis, or Lou Gehrig's disease, according to a new study by researchers at the University of Pittsburgh School of Medicine.

25 Apr 2013

Research reveals that molecular madness goes on in the brain after blast exposure

A multicenter study led by scientists at the University of Pittsburgh School of Medicine shows that mild traumatic brain injury after blast exposure produces inflammation, oxidative stress and gene activation patterns akin to disorders of memory processing such as Alzheimer's disease.

25 Apr 2013

Scientists to develop technology for unprecedented new understanding of how the brain works

The newly proposed scientific project to understand the most complicated 3 pounds of material in the world - the human brain - is the topic of an article in the current edition of Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.

25 Apr 2013

New study shows Achilles tendon injuries more common among male athletes

Male athletes are the group most likely to tear their Achilles tendon, according to a new study published in the April 2013 issue of Foot & Ankle International, A SAGE journal.

25 Apr 2013

Research paper focuses on social factors involved in back pain sufferers

Researchers at the University of Huddersfield have published a research paper that focuses on the social factors involved in back pain sufferers returning to work, to give a wider context to the medical factors that are often considered.

25 Apr 2013

MCCIR scientists use video imaging to investigate effectiveness of rituximab in killing cancerous B cells

Scientists from the Manchester Collaborative Centre for Inflammation Research have discovered why a particular cancer drug is so effective at killing cells.

From The University of Manchester 25 Apr 2013

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for sight threatening eye diseases, today announced that a phase 2b/3 clinical trial investigating emixustat hydrochloride in subjects with geographic atrophy associated with dry age-related macular degeneration has been initiated.

25 Apr 2013

Study finds link between 2 genetic markers and post-concussion neurocognitive function

A new study presented last week is coming one step closer to finding out whether or not an athlete's genetic makeup determines the severity of post-concussive brain function.

25 Apr 2013

Novel approach using Listeria bacteria shows promise against metastatic pancreatic cancer

Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them.

25 Apr 2013

XBiotech announces enrollment of first patient in Xilonix Phase III trial for treatment of cachexia

XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.

25 Apr 2013

Omega-3 polyunsaturated fatty acids associated with lower risk of heart failure mortality in adults

Omega-3 polyunsaturated fatty acids, namely DHA and EPA found in fatty fish, are associated with lower risk of heart failure mortality in adults with chronic heart failure or who have experienced a heart attack.

25 Apr 2013

FDA designates Merck's lambrolizumab as Breakthrough Therapy for advanced melanoma

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has designated lambrolizumab (MK-3475) as a Breakthrough Therapy for the treatment of patients with advanced melanoma.

25 Apr 2013

Higher TMAO blood levels linked to increased risk of heart disease

A microbial byproduct of intestinal bacteria contributes to heart disease and serves as an accurate screening tool for predicting future risks of heart attack, stroke and death in persons not otherwise identified by traditional risk factors and blood tests, according to Cleveland Clinic research published today in The New England Journal of Medicine.

25 Apr 2013

Astrocytes more effective in promoting recovery after brain injury

The production of a certain kind of brain cell that had been considered an impediment to healing may actually be needed to staunch bleeding and promote repair after a stroke or head trauma, researchers at Duke Medicine report.

25 Apr 2013

Long-term exposure to air pollution linked to heart attacks, strokes

Long-term exposure to air pollution may be linked to heart attacks and strokes by speeding up atherosclerosis, or "hardening of the arteries," according to a University of Michigan public health researcher and colleagues from across the U.S.

25 Apr 2013

Medical Condition News

Talk therapy improves PTSD, says Walter Reed National Military Medical Center chief

Thought Leaders Consortium discusses new vision for medicine in healthcare

Perosphere, Daiichi Sankyo sign clinical trial agreement

Omeros presents clinical data of OMS302 on reducing pupil constriction during ILR at ASCRS meeting

Personalized knee replacement: an interview with Dr Martin, Preferred Orthopedics of the Palm Beaches

Study: Melatonin delays symptom onset, reduces mortality in mouse model of ALS

Research reveals that molecular madness goes on in the brain after blast exposure

Scientists to develop technology for unprecedented new understanding of how the brain works

New study shows Achilles tendon injuries more common among male athletes

Research paper focuses on social factors involved in back pain sufferers

MCCIR scientists use video imaging to investigate effectiveness of rituximab in killing cancerous B cells

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Study finds link between 2 genetic markers and post-concussion neurocognitive function

Novel approach using Listeria bacteria shows promise against metastatic pancreatic cancer

XBiotech announces enrollment of first patient in Xilonix Phase III trial for treatment of cachexia

Omega-3 polyunsaturated fatty acids associated with lower risk of heart failure mortality in adults

FDA designates Merck's lambrolizumab as Breakthrough Therapy for advanced melanoma

Higher TMAO blood levels linked to increased risk of heart disease

Astrocytes more effective in promoting recovery after brain injury

Long-term exposure to air pollution linked to heart attacks, strokes

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News